Dr. Srinivasu Moparty, M.D.
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Tulane University School of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 174
Licensed in Texas since 2008, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Tulane University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
TX license M8852 (first issued 2008; active) -
Internal Medicine Physician
TX license M8852 (first issued 2008; active) -
Student in an Organized Health Care Education/Training Program
TX license BP10025319
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Methodist Dallas Medical Center Dallas, TX
- Methodist Charlton Medical Center Dallas, TX
- Methodist Midlothian Medical Center Midlothian, TX
Medical groups
- Texas Oncology PA (1,014 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 174
- Services billed
- 24,656
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 509 | 143 |
| Injection, dexamethasone sodium phosphate, 1 mg | 500 | 16 |
| Insertion of needle into vein for collection of blood sample | 483 | 142 |
| Established patient office or other outpatient visit, 30-39 minutes | 457 | 118 |
| Injection, granisetron hydrochloride, 100 mcg | 280 | 11 |
| Blood test, comprehensive group of blood chemicals | 179 | 91 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 75 | 23 |
| Administration of chemotherapy into vein, 1 hour or less | 70 | 26 |
| Injection of drug or substance under skin or into muscle | 38 | 14 |
| Injection of additional new drug or substance into vein | 36 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Letrozole Other prescribers in Dallas, TX | 118 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Dallas, TX | 52 |
| Gabapentin Other prescribers in Dallas, TX | 50 |
| Eliquis (apixaban) Other prescribers in Dallas, TX | 45 |
| Dexamethasone Other prescribers in Dallas, TX | 45 |
| Ondansetron Hcl Other prescribers in Dallas, TX | 35 |
| Lidocaine-Prilocaine (lidocaine/prilocaine) Other prescribers in Dallas, TX | 24 |
| Megestrol Acetate Other prescribers in Dallas, TX | 23 |
| Ondansetron Odt (ondansetron) Other prescribers in Dallas, TX | 21 |
| Promethazine Hcl Other prescribers in Dallas, TX | 21 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 26 payments worth $574 in total to this clinician.
| Pfizer Inc. | $88.92 |
|---|---|
| AbbVie Inc. | $86.08 |
| Tempus Ai, Inc | $76.23 |
| E.r. Squibb & Sons, L.l.c. | $67.29 |
| Genzyme Corporation | $61.30 |
| Celgene Corporation | $31.20 |
| Astellas Pharma US Inc | $28.39 |
| Ipsen Biopharmaceuticals, Inc | $25.93 |
| Food and Beverage | $574 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.